We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Natural Bypass Score May Guide Care in Chronic Coronary Blockages

By HospiMedica International staff writers
Posted on 03 Jun 2026
Chronic total occlusion, a complete coronary artery blockage present for months, poses difficult treatment decisions in coronary artery disease. More...
Opening these arteries is technically demanding and carries procedural risk, while advanced imaging to assess downstream myocardial viability is not always available. As a result, identifying which patients are most likely to benefit from revascularization remains a common challenge in catheter laboratories. A new study shows that a simple angiographic score of the heart’s natural collateral “bypass” vessels can guide viability assessment and spare some patients from unnecessary invasive procedures.
 
Researchers at the University of East Anglia (Norwich, UK), working with Norfolk and Norwich University Hospital, evaluated the Rentrop collateral score, an angiographic grading system of coronary “natural bypass” vessels. The score is derived during routine coronary angiography and reflects the effectiveness of collateral flow to myocardium beyond an occlusion. The investigation asked whether this readily available measure can indicate myocardial viability without immediate reliance on advanced imaging. 
 
Investigators analyzed patients with chronic total occlusion, defined as a completely blocked coronary artery persisting for months. They compared the Rentrop score with cardiac magnetic resonance imaging (MRI), regarded as the reference standard for distinguishing viable from permanently scarred myocardium. The analysis assessed how collateral grade aligned with downstream tissue viability. 
 
The cohort included 56 patients with completely occluded coronary arteries. Patients with stronger collateralization, defined as a Rentrop score above one, were more likely to have living myocardium despite the blockage. The Rentrop score was the only independent predictor of viability, and each one-step increase more than doubled the likelihood that the affected myocardium remained alive. Findings were published on May 31, 2026, in Open Heart, in a study led by the University of East Anglia with the Norfolk and Norwich University Hospitals NHS Foundation Trust and Leiden University Medical Centre. 
 
Opening a completely blocked artery is described as long, complex, and resource‑intensive, and not every patient benefits. Using information already visible on an angiogram could help clinicians decide who warrants further testing, prioritize MRI for those most likely to benefit, and avoid unnecessary procedures. The approach may be especially useful in settings where immediate access to cardiac MRI is limited. 
 
“We hope that our work could help doctors make faster, more informed decisions in the catheter laboratory, especially when advanced cardiac MRI is not immediately available. By simply looking at what’s already visible during a routine angiogram, doctors can quickly identify patients worth investigating further, prioritize MRI scans for those who need them most and avoid unnecessary procedures in patients unlikely to benefit. In other words, it could mean faster decisions, fewer risks, and better outcomes,” said Dr. Pankaj Garg, from UEA’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital.

Related Links

UEA’s Norwich Medical School

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.